NeuroPace (NPCE) Inventory (2020 - 2026)

NeuroPace's Inventory history runs 7 years deep, the most recent figure standing at $16.7 million for Q1 2026.

• On a quarterly basis, Inventory rose 22.93% year-over-year to $16.7 million in Q1 2026; TTM through Mar 2026 was $16.7 million, a 22.93% increase from a year earlier, with the FY2025 full-year figure at $16.9 million, up 26.27% from the prior year.
• Inventory eased to $16.7 million in Q1 2026 per NPCE's latest filing, from $16.9 million in the prior quarter.
• Across five years, Inventory topped out at $18.1 million in Q3 2025 and bottomed at $8.1 million in Q1 2022.
• The 5-year median for Inventory is $11.4 million (2024), against an average of $12.1 million.
• Across the five-year window, Inventory increased 6.2% in 2024 and surged 50.07% in 2025, its largest moves.
• Year by year, Inventory stood at $9.7 million in 2022, then gained by 15.47% to $11.2 million in 2023, then increased by 19.32% to $13.4 million in 2024, then advanced by 26.27% to $16.9 million in 2025, then decreased by 1.2% to $16.7 million in 2026.
• Per Business Quant, the three latest NPCE Inventory figures stand at $16.7 million (Q1 2026), $16.9 million (Q4 2025), and $18.1 million (Q3 2025).